Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors

NCT02534506 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Tumors

Interventions

DRUG: Urelumab
DRUG: Nivolumab

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]